Suppr超能文献

跨膜螺旋3和6的胞质端的排斥性分离与一种新型促甲状腺激素受体突变体(M626I)中的受体激活有关。

Repulsive separation of the cytoplasmic ends of transmembrane helices 3 and 6 is linked to receptor activation in a novel thyrotropin receptor mutant (M626I).

作者信息

Ringkananont Usanee, Van Durme Joost, Montanelli Lucia, Ugrasbul Figen, Yu Y Miles, Weiss Roy E, Refetoff Samuel, Grasberger Helmut

机构信息

Department of Medicine, The University of Chicago, Chicago, Illinois 60637, USA.

出版信息

Mol Endocrinol. 2006 Apr;20(4):893-903. doi: 10.1210/me.2005-0339. Epub 2005 Dec 8.

Abstract

Ligand-dependent activation of G protein-coupled receptors (GPCRs) involves repositioning of the juxtacytoplasmic ends of transmembrane helices TM3 and TM6. This concept, inferred from site-directed spin labeling studies, is supported by chemical cross-linking of the cytoplasmic ends of TM3 and TM6 blocking GPCR activation. Here we report a novel constitutive active mutation (M626I) in TM6 of the TSH receptor (TSHR), identified in affected members of a family with nonautoimmune hyperthyroidism. The specific constitutive activity of M626I, measured by its basal cAMP generation corrected for cell surface expression, was 13-fold higher than that of wild-type TSHR. Homology modeling of the TSHR serpentine domain based on the rhodopsin crystal structure suggests that M626 faces the side chain of I515 of TM3 near the membrane-cytoplasmic junction. Steric hindrance of the introduced isoleucine by I515 is consistent with the fact that shorter or more flexible side chains at position 626 did not increase constitutivity. Furthermore, a reciprocal mutation at position 515 (I515M), when introduced into the M626I background, acts as revertant mutation by allowing accommodation of the isoleucine sidechain at position 626 and fully restoring the constitutive activity to the level of wild-type TSHR. Thus, repulsive separation of the juxtacytoplasmic TM6 and TM3 in the M626I model conclusively demonstrates a direct link between the opening of this cytoplasmic face of the receptor structure and G protein coupling.

摘要

G蛋白偶联受体(GPCRs)的配体依赖性激活涉及跨膜螺旋TM3和TM6近胞质端的重新定位。这一概念是从定点自旋标记研究中推断出来的,通过TM3和TM6胞质端的化学交联阻断GPCR激活得到了支持。在此,我们报告了促甲状腺激素受体(TSHR)的TM6中一个新的组成型活性突变(M626I),该突变是在一个患有非自身免疫性甲状腺功能亢进症家族的患病成员中发现的。通过针对细胞表面表达校正的基础cAMP生成量来衡量,M626I的特定组成型活性比野生型TSHR高13倍。基于视紫红质晶体结构对TSHR蛇形结构域进行的同源建模表明,M626在膜 - 胞质交界处附近面向TM3的I515的侧链。I515对引入的异亮氨酸的空间位阻与626位较短或更灵活的侧链不会增加组成型活性这一事实一致。此外,当在M626I背景中引入515位的反向突变(I515M)时,它作为回复突变起作用,通过允许626位异亮氨酸侧链的容纳并将组成型活性完全恢复到野生型TSHR的水平。因此,M626I模型中近胞质TM6和TM3的排斥性分离最终证明了受体结构的这一胞质面的开放与G蛋白偶联之间的直接联系。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验